Senior Director, Early Differentiation & Pipeline Strategy (EDAPS), Oncology

Scorpion Therapeutics; Princeton (NJ); Hybrid; USD 250,000 - 450,000; Full time

Job summary

Scorpion Therapeutics seeks a Senior Director, Early Differentiation & Pipeline Strategy (EDAPS) within Global Medical Oncology to drive early-stage hematology and oncology asset strategies from candidate selection to proof-of-concept. You will shape evidence plans, differentiation narratives, and publication strategies while coordinating with R&D, Medical, and Commercial teams.

The role requires an MD/PhD/PharmD with 8–10 years in clinical, medical, or pharma settings, and excellent

Qualifications

• MD/PhD/PharmD or equivalent clinical qualification.
• 8–10 years in clinical, medical, or pharma industries with oncology/hematology exposure.
• Strong understanding of early drug development and clinical trial design.
• Proven stakeholder engagement and matrix management skills.
• Excellent communication abilities across multiple stakeholders.

Responsibilities

• Develop and execute global medical strategies for a subset of assets, including evidence generation, publication, and communication plans.
• Collaborate with R&D, Medical, and Commercial teams to align on strategy and execution.
• Engage with thought leaders and patient advocacy groups to inform programs.
• Lead advisory boards and capture actionable insights for asset development.
• Ensure clinical differentiation and optimize asset potential through integrated evidence plans and scientific narratives.

Skills

Stakeholder engagement

Matrix management

Clinical trial design

Scientific communication

Early development knowledge

Education

MD/PhD/PharmD

Job description

Role: Senior Director, Early Differentiation & Pipeline Strategy (EDAPS) within Global Medical Oncology, focusing on early-stage hematology and oncology assets from candidate selection to clinical proof-of-concept.

Responsibilities:

• develop and execute global medical strategies for a subset of assets, including evidence generation, publication, and communication plans


• collaborate with R&D, Medical, and Commercial teams


• engage with thought leaders and patient advocacy groups


• lead advisory boards


• ensure clinical differentiation and optimize asset potential through integrated evidence plans and scientific narratives

Requirements:

• MD, PharmD, or PhD


• 8-10 years in clinical, medical, or pharma industries with experience in malignant hematology or oncology


• strong understanding of early drug development, scientific science, and clinical trial design


• proven stakeholder engagement and matrix management skills


• excellent communication abilities

HighValue:

• therapeutic areas include hematology/oncology, early development stages (candidate to proof-of-concept), cross-functional medical strategy, external scientific engagement, and advisory board leadership

WorkSetup: not specified, likely hybrid or remote based on role scope.